Showing results (11-20 of 206) with videos related to
Sort By:
Pageof 21
Cells|October 27, 2022
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIPKarthik Nagaraj, Rive Sarfstein, Zvi Laron, et al.Cells|November 13, 2020
Laron Syndrome Research Paves the Way for New Insights in Oncological InvestigationHaim Werner, Rive Sarfstein, Karthik Nagaraj, et al.Endocrine Connections|January 18, 2014
Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cellsDoron Weinstein, Rive Sarfstein, Zvi Laron, et al.Expert Opinion on Biological Therapy|January 12, 2011
Controversies in the use of insulin analoguesHaim Werner, Doron Weinstein, Einat Yehezkel, et al.Mutation Research. Reviews in Mutation Research|May 23, 2017
IGF-I deficiency, longevity and cancer protection of patients with Laron syndromeZvi Laron, Rivka Kauli, Lena Lapkina, et al.Diabetes/Metabolism Research and Reviews|January 16, 2009
Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cellsDoron Weinstein, Meital Simon, Einat Yehezkel, et al.Diabetes/Metabolism Research and Reviews|August 22, 2013
Letter to the Editor - responses to Weisntein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and antiactivity in cultured cancer cellsDoron Weinstein, Meital Simon, Einat Yehezkel, et al.Diabetes/Metabolism Research and Reviews|June 29, 2010
The mitogenicity of insulin analogues in vitro relative to insulin and IGF-I - Response to Kazda et alDoron Weinstein, Meital Simon, Einat Yehezkel, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2020
Identification of nephronectin as a new target for IGF1 actionRive Sarfstein, Lena Lapkina-Gendler, Karthik Nagaraj, et al.Molecular and Cellular Endocrinology|February 21, 2015
Proliferative and signaling activities of insulin analogues in endometrial cancer cellsDaniel Aizen, Rive Sarfstein, Ilan Bruchim, et al.Pageof 21